Brief: Lipocine Inc says On May 10 Board Of Directors Approved A Reverse Stock Split Ratio Of 1-For-17
11/05/2023 18:03
May 11 (Reuters) - Lipocine Inc:
* LIPOCINE INC - ON MAY 10 BOARD OF DIRECTORS APPROVED A
REVERSE
STOCK SPLIT RATIO OF 1-FOR-17
* LIPOCINE INC - SHARES WILL BEGIN TRADING ON A
SPLIT-ADJUSTED
BASIS ON NASDAQ CAPITAL MARKET COMMENCING UPON MARKET OPEN ON
MAY 12
Further company coverage: LPCN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lipocine
See all newsUS STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
U.S. STOCKS ON THE MOVE-Hecla Mining, XPO, Lipocine
Lipocine surges after Canada approves co's testosterone replacement therapy
Brief: Lipocine Announces Health Canada Approval Of Tlando For Testosterone Replacement Therapy